MRNA Stock: Price, Earnings History and SEC Filings
Moderna, Inc. (MRNA) last traded at $221.72, down 0.47% on the latest session and up 15.1% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-1.97 against an analyst estimate of $-1.97, a beat of 0.0%.
$221.72 -0.47%
1 month+15.14%
52-week high$254.48
52-week low$22.28
Volume9.01M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
MRNA earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Jul 31, 2026 | $-1.97 | $-1.97 | +0.00% |
| Mar 2026 | May 1, 2026 | $-1.18 | $-3.02 | +60.93% |
| Dec 2025 | Feb 13, 2026 | $-2.11 | $-2.60 | +18.85% |
| Sep 2025 | Nov 6, 2025 | $-0.51 | $-2.15 | +76.28% |
MRNA beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for MRNA
SEC filing data is not available right now. You can search for MRNA on SEC EDGAR.
MRNA news
- Jobs, Midterm Elections, Apple, Palantir, McDonald’s, Moderna, and More to Watch This WeekNov 1, 2026 · finance.yahoo.com
- Merck stock rises as its cancer strategy gets personalNov 1, 2026 · thestreet.com
- What To Expect In Markets This Week: AAPL, PLTR, AMD, SMCI, SHOP, Earnings, Jobs Report And MoreNov 1, 2026 · stocktwits.com
- How Investors Are Reacting To Moderna Stock Phase 3 Melanoma Vaccine DataOct 31, 2026 · finance.yahoo.com
- This week in charts: ESMO’s winners and losersOct 30, 2026 · biopharmadive.com
- Prediction markets herald insider trading risks for private biotechsOct 30, 2026 · pharmaceutical-technology.com
- Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to DeclineOct 30, 2026 · finance.yahoo.com
- Merck & Co., Inc. Q3 Earnings Call HighlightsOct 30, 2026 · marketbeat.com
About Moderna, Inc.
Moderna, Inc. (MRNA) is a US-listed public company on Nasdaq.